EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Effects of Tafamidis Meglumine on Transient Focal Neurological Episodes and Meningeal Contrast Enhancement in Hereditary Transthyretin‐Related Meningeal Amyloidosis: Report of Two Patients Carrying the c.265T>C (p.Y89H) Variant

Natsumi Saito iD, Yasuko Kuroha, Ayaka Ishiyama, Takahiro Wakasugi, Takayoshi Tokutake, Arika Hasegawa, Tetsuya Takahashi

Brain and Behavior · 2025

DOI: 10.1002/brb3.70856 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Brain and Behavior, 2025. Verfasst von Natsumi Saito und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Benzoxazoles. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Y69H (p.Y89H) variant hereditary transthyretin (ATTRv) amyloidosis causes meningeal amyloidosis, with mutant TTR deposits localized to the leptomeninges and vitreous body.

Methods

The effect of tafamidis meglumine on neurological disorders, such as the frequency of transient focal neurological episodes (TFNEs), magnetic resonance imaging (MRI) findings, and TTR levels in cerebrospinal fluid, was investigated in two patients diagnosed with Y69H ATTRv mutation.

Results

The initial symptoms in both patients were TFNEs, such as aphasia, sensory disturbance, motor paralysis, ataxia, and drop attacks. Neither epileptic drugs nor antiplatelet therapy decreased the frequency of attacks. The patients exhibited diffuse leptomeningeal enhancement on brain and spinal MRI. Tafamidis meglumine was initiated at a dose of 20 mg/day and was found to be partially effective. The TFNEs nearly resolved, and meningeal enhancement on brain MRI improved; however, the neurological deficits progressed over the following 2 years.

Conclusions

Tafamidis had a partial effect on TFNEs and meningeal contrast enhancement on MRI; however, cerebellar ataxia and cognitive decline continued to progress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialBenzoxazolesHumansBrainMagnetic Resonance ImagingMeningesMutationPrealbumin

Stichwörter der Autor:innen

TFNEsY69Hhereditary ATTR amyloidosistafamidis meglumine

Substanzen

BenzoxazolesPrealbumintafamidis

Autor:innen und Institutionen

  • Department of Neurology, NHO Nishiniigata Chuo Hospital, Niigata, Japan.

ORCID-Profile: Natsumi Saito

Zitieren

APA

Saito, N., Kuroha, Y., Ishiyama, A., Wakasugi, T., Tokutake, T., Hasegawa, A., & Takahashi, T. (2025). Effects of Tafamidis Meglumine on Transient Focal Neurological Episodes and Meningeal Contrast Enhancement in Hereditary Transthyretin‐Related Meningeal Amyloidosis: Report of Two Patients Carrying the c.265T>C (p.Y89H) Variant. Brain and Behavior. https://doi.org/10.1002/brb3.70856

Vancouver

Saito N, Kuroha Y, Ishiyama A, Wakasugi T, Tokutake T, Hasegawa A, et al. Effects of Tafamidis Meglumine on Transient Focal Neurological Episodes and Meningeal Contrast Enhancement in Hereditary Transthyretin‐Related Meningeal Amyloidosis: Report of Two Patients Carrying the c.265T>C (p.Y89H) Variant. Brain and Behavior. 2025. doi:10.1002/brb3.70856

BibTeX
@article{Saito2025,
  author = {Saito, Natsumi and Kuroha, Yasuko and Ishiyama, Ayaka and Wakasugi, Takahiro and Tokutake, Takayoshi and Hasegawa, Arika and Takahashi, Tetsuya},
  title = {Effects of Tafamidis Meglumine on Transient Focal Neurological Episodes and Meningeal Contrast Enhancement in Hereditary Transthyretin‐Related Meningeal Amyloidosis: Report of Two Patients Carrying the c.265T>C (p.Y89H) Variant},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70856}
}
Kostenlos starten →